UCLA Researchers & Innovators
Industry & Investors
News & Events
About
Concierge
Search Results - kouki+morizono
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Targeted Lentiviral Transduction of B-Cells With Desired B-Cell Receptor Specificity (UCLA Case No. 2023-237)
UCLA researchers in the Division of Hematology and Oncology in the Department of Medicine, have discovered novel lentiviral vectors that can be used for gene delivery to B-cells and for the development of neutralizing antibodies against viruses. BACKGROUND: Microbial tropism is a microbiology term that describes the types of animals (including human),...
Published: 3/15/2024
|
Inventor(s):
Kouki Morizono
Keywords(s):
B Cell
,
cell receptor
,
COVID-19
,
VIral entry
,
Virus
Category(s):
Therapeutics > Immunology And Immunotherapy
2000-128 TARGETING LENTIVIRAL VECTORS TO SPECIFIC CELLS AND TISSUES
SummaryResearchers in the UCLA Departments of Medicine and Microbiology, Immunology and Molecular Genetics have developed retroviral vectors pseudotyped with a modified Sinbus virus envelope that exhibit reduced tropism and can be used for the targeted transduction of heterologous genes into cells.BackgroundThere have been numerous attempts to develop...
Published: 7/19/2023
|
Inventor(s):
Irvin S.Y. Chen
,
Kouki Morizono
Keywords(s):
Drug Delivery
,
Gene Editing Systems
,
Gene Therapy
,
Therapeutics & Vaccines
Category(s):
Platforms > Drug Delivery
,
Therapeutics
,
Therapeutics > Gene Therapy And Editing